Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …

Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …

Medication-related osteonecrosis of the jaw (MRONJ) is now a well-known complication
associated with antiresorptive and antiangiogenic therapies that is affecting a growing …

Background The effectiveness of management strategies used for the treatment of
medication-related osteonecrosis of the jaw (MRONJ) remains poorly understood. The …

The purpose of this study was to identify the patient populations at risk of medication‐related
osteonecrosis of the jaw (MRONJ) and determine which medical and dental comorbidities …

Purpose The treatment of patients with medication-related osteonecrosis of the jaw
(MRONJ) is challenging. The purpose of the present study was to estimate the frequency …

Skeletal complications caused by osteoporosis or bone metastases are associated with
considerable pain, increased mortality, and reduced quality of life. Furthermore, such events …

This article has 2 primary goals: to provide the best current frequency estimate of medication-
related osteonecrosis of the jaws (MRONJ) and to identify factors associated with the risk of …

The medication-related osteonecrosis of the jaw (MRONJ) is believed to be a therapy-
resistant entity. Although the application of the recommended conservative and surgical …

Medication‐related osteonecrosis of the jaw (MRONJ) is an adverse event that may inhibit
the treatment of primary disease and remarkably influence the patient's quality of life. The …